HYPERBILIRUBINAEMIA side effect
What is HYPERBILIRUBINAEMIA ?Drugs associated with HYPERBILIRUBINAEMIA
ACETYLSALICYLIC ALDURAZYME APTIVUS ATAZANAVIR AUGMENTIN AVASTIN BACTRIM BEVACIZUMAB BUSULFAN CEFAZOLIN CEFUROXIME CIPRO CISPLATIN CLINDAMYCIN CLOLAR CYTARABINE DACTINOMYCIN DASATINIB DULOXETINE EMTRICITABINE EPIVIR EPZICOM ERBITUX ETONOGESTREL FINIBAX GEMTUZUMAB KALETRA LAPATINIB LEVAQUIN MESALAMINE MYLOTARG NEBILET NEOPROFEN NORFLOXIN NOVANTRONE ORTHO PLAVIX PRIMAXIN PROGRAF RIFADIN RITONAVIR RITUXIMAB ROSIGLITAZONE SEROQUEL SUPACEF SUTENT TAXOL TAZOCEL TEMOZOLOMIDE TICLOPIDINE TOPAMAX TRIFLUCAN TRUVADA TYKERB UNASYN VELCADE VFEND WARFARIN ZOLOFTHYPERBILIRUBINAEMIA : Nebilet Side Effects Report #5661853-2
Physician from GERMANY reported NEBILET problem on Mar 06, 2008. Male patient, 70 years of age, was treated with NEBILET. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, . NEBILET dosage: unknown. During the same period patient was treated with ASPIRIN, SPIRIVA, ACETYLCYSTEINE, FUROSEMIDE, DIGOXIN, MARCUMAR, SIMVASTATIN, THIAMAZOL. Patient recovered.
HYPERBILIRUBINAEMIA : Cefuroxime Side Effects Report #5589701-X
CEFUROXIME problem was reported by a Physician from INDIA on Jan 04, 2008. Female patient, 27 years of age, was diagnosed with prophylaxis and was treated with CEFUROXIME. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . CEFUROXIME dosage: 750MG THREE TIMES PER DAY. During the same period patient was treated with AUGMENTIN. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Supacef Side Effects Report #5591840-4
Physician from INDIA reported SUPACEF problem on Jan 14, 2008. Male patient, 49 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Supacef Side Effects Report #5591841-6
SUPACEF problem was reported by a Physician from INDIA on Jan 14, 2008. Male patient, 78 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Supacef Side Effects Report #5591842-8
Physician from INDIA reported SUPACEF problem on Jan 14, 2008. Male patient, 76 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Supacef Side Effects Report #5591843-X
SUPACEF problem was reported by a Physician from INDIA on Jan 14, 2008. Male patient, 63 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Supacef Side Effects Report #5591844-1
Physician from INDIA reported SUPACEF problem on Jan 14, 2008. Male patient, 50 years of age, was treated with SUPACEF. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . SUPACEF dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Emtricitabine Side Effects Report #5603048-4
EMTRICITABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 16, 2008. Female patient, 34 years of age, weighting 116.8 lb, was diagnosed with hiv infection, pulmonary tuberculosis, medical diet and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, PYRIDOXINE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Finibax Side Effects Report #5604725-1
Health Professional from JAPAN reported FINIBAX problem on Jan 17, 2008. Female patient was diagnosed with sepsis, infection prophylaxis and was treated with FINIBAX. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hyperkalaemia, septic shock, . FINIBAX dosage: unknown. During the same period patient was treated with PRODIF, POTASSIUM CHLORIDE, OMEGACIN, MAXIPIME, LASIX, PAXIL, DEPAS. Patient died on 11/21/2006.
HYPERBILIRUBINAEMIA : Clolar Side Effects Report #5627237-8
CLOLAR problem was reported by a Health Professional from UNITED KINGDOM on Dec 05, 2007. Male patient was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, pneumonia fungal, . CLOLAR dosage: unknown. Patient was hospitalized. Patient died on 11/27/2007.
HYPERBILIRUBINAEMIA : Emtricitabine Side Effects Report #5570160-8
Consumer or non-health professional from UNITED STATES reported EMTRICITABINE problem on Dec 12, 2007. Female patient, 34 years of age, weighting 116.8 lb, was diagnosed with hiv infection, pulmonary tuberculosis, medical diet and was treated with EMTRICITABINE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . EMTRICITABINE dosage: unknown. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, EFAVIRENZ, ISONIAZID, RIFAMPICIN, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, PYRIDOXINE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Seroquel Side Effects Report #5473271-0
SEROQUEL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2007. Female patient was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, neutropenia, . SEROQUEL dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Taxol Side Effects Report #5479275-6
Physician from JAPAN reported TAXOL problem on Oct 01, 2007. Female patient, 70 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, inappropriate antidiuretic hormone secretion, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN, TRICHLORMETHIAZIDE, KYTRIL, DECADRON, RESTAMIN. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Tykerb Side Effects Report #5482589-7
TYKERB problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Female patient was diagnosed with ovarian disorder and was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . TYKERB dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Duloxetine Side Effects Report #5443258-2
Physician from RUSSIAN FEDERATION reported DULOXETINE HYDROCHLORIDE problem on Aug 22, 2007. Female patient, 22 years of age, was diagnosed with depression and was treated with DULOXETINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . DULOXETINE HYDROCHLORIDE dosage: 120 MG, DAILY (1/D). During the same period patient was treated with AMITRIPTYLINE, DIPHENHYDRAMINE, METAMIZOL SODIQUE, DICLOFENACO. Patient recovered.
HYPERBILIRUBINAEMIA : Avastin Side Effects Report #5445564-4
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Aug 23, 2007. Male patient, 50 years of age, weighting 280.0 lb, was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . AVASTIN dosage: unknown. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Cisplatin Side Effects Report #5446072-7
Health Professional from UNITED STATES reported CISPLATIN problem on Aug 24, 2007. Male patient, 62 years of age, was diagnosed with metastatic gastric cancer, prophylaxis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hyperglycaemia, jaundice cholestatic, lobar pneumonia, metabolic acidosis, renal failure, . CISPLATIN dosage: unknown. During the same period patient was treated with DEXAMETHASONE, EMEND, LORAZEPAM, ONDANSETRON. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Topamax Side Effects Report #5407364-0
TOPAMAX problem was reported by a Physician from SERBIA AND MONTENEGRO on May 30, 2007. Male patient, weighting 4.63 lb, was treated with TOPAMAX. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, intraventricular haemorrhage neonatal, . TOPAMAX dosage: unknown. During the same period patient was treated with LAMOTRIGINE, VALPROATE. Patient recovered.
HYPERBILIRUBINAEMIA : Duloxetine Side Effects Report #5418140-7
Physician from RUSSIAN FEDERATION reported DULOXETINE HYDROCHLORIDE problem on Aug 03, 2007. Female patient, 22 years of age, was diagnosed with depression and was treated with DULOXETINE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . DULOXETINE HYDROCHLORIDE dosage: 120 MG, DAILY (1/D). During the same period patient was treated with AMITRIPTYLINE, DIPHENHYDRAMINE, METAMIZOL SODIQUE, DICLOFENACO. Patient recovered.
HYPERBILIRUBINAEMIA : Bevacizumab Side Effects Report #5425510-X
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Aug 14, 2007. Male patient, 53 years of age, weighting 229.3 lb, was diagnosed with follicular thyroid cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, hyponatraemia, . BEVACIZUMAB dosage: 10 MG/KG, D1,15,29. During the same period patient was treated with SUNITINIB MALATE. Patient recovered.
HYPERBILIRUBINAEMIA : Sutent Side Effects Report #5377729-4
Physician from FRANCE reported SUTENT problem on June 21, 2007. Female patient, 45 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, liver disorder, thrombocytopenia, . SUTENT dosage: DAILY DOSE:50MG. Patient recovered.
HYPERBILIRUBINAEMIA : Lapatinib Side Effects Report #5384198-7
LAPATINIB problem was reported by a Physician from ITALY on July 04, 2007. Female patient, 44 years of age, weighting 372.6 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, ill-defined disorder, thrombocytopenia, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Neoprofen Side Effects Report #5386297-2
Pharmacist from UNITED STATES reported NEOPROFEN problem on July 10, 2007. Male patient, weighting 2.22 lb, was diagnosed with patent ductus arteriosus and was treated with NEOPROFEN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . NEOPROFEN dosage: unknown. During the same period patient was treated with CEFOTAXIME, CLINDAMYCIN, IV FAT EMULSIONK, FENTANYL, TOBRAMYCIN, VANCOMYCIN, DOPAMINE. Patient recovered.
HYPERBILIRUBINAEMIA : Sutent Side Effects Report #5377729-4
SUTENT problem was reported by a Physician from FRANCE on June 21, 2007. Female patient, 45 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, jaundice, liver disorder, thrombocytopenia, . SUTENT dosage: DAILY DOSE:50MG. Patient recovered.
HYPERBILIRUBINAEMIA : Lapatinib Side Effects Report #5384198-7
Physician from ITALY reported LAPATINIB problem on July 04, 2007. Female patient, 44 years of age, weighting 372.6 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, ill-defined disorder, thrombocytopenia, . LAPATINIB dosage: 1250MGM2 PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Neoprofen Side Effects Report #5386297-2
NEOPROFEN problem was reported by a Pharmacist from UNITED STATES on July 10, 2007. Male patient, weighting 2.22 lb, was diagnosed with patent ductus arteriosus and was treated with NEOPROFEN. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, . NEOPROFEN dosage: unknown. During the same period patient was treated with CEFOTAXIME, CLINDAMYCIN, IV FAT EMULSIONK, FENTANYL, TOBRAMYCIN, VANCOMYCIN, DOPAMINE. Patient recovered.
HYPERBILIRUBINAEMIA : Norfloxin Side Effects Report #5648922-8
Physician from JAPAN reported NORFLOXIN problem on Feb 25, 2008. Female patient, 30 years of age, was diagnosed with nasopharyngitis, infection prophylaxis and was treated with NORFLOXIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, hyperbilirubinaemia, ileus, pleurisy, small intestine ulcer, toxic epidermal necrolysis, . NORFLOXIN dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, ACETAMINOPHEN, IMIPENEM. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Vfend Side Effects Report #5664871-3
VFEND problem was reported by a Consumer or non-health professional from JAPAN on Mar 04, 2008. Male patient, weighting 115.7 lb, was diagnosed with pneumonia bacterial, cardiac failure congestive and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: cardiac failure, hyperbilirubinaemia, renal failure acute, respiratory failure, thrombotic microangiopathy, . VFEND dosage: unknown. During the same period patient was treated with BIAPENEM, ORGARAN, MINOMYCIN, BENAMBAX, TARGOCID, GAMIMUNE N. Patient was hospitalized. Patient died on 08/08/2006.
HYPERBILIRUBINAEMIA : Tazocel Side Effects Report #5626601-0
Health Professional from SPAIN reported TAZOCEL problem on Feb 06, 2008. Female patient, 30 years of age, was diagnosed with liver abscess, fascioliasis and was treated with TAZOCEL. After drug was administered, patient experienced the following problems/side effects: hepatocellular injury, hyperbilirubinaemia, . TAZOCEL dosage: unknown. During the same period patient was treated with PARACETAMOL, ESKAZOLE. Patient recovered.
HYPERBILIRUBINAEMIA : Augmentin Side Effects Report #5632109-9
AUGMENTIN problem was reported by a Consumer or non-health professional from GREECE on Feb 12, 2008. Female patient, child 5 years of age, was diagnosed with lower respiratory tract infection and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: coagulation time prolonged, hyperbilirubinaemia, jaundice, ocular icterus, transaminases increased, . AUGMENTIN dosage: 8ML THREE TIMES PER DAY. During the same period patient was treated with AEROLIN, FLIXOTIDE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Mylotarg Side Effects Report #5584230-1
Physician from JAPAN reported MYLOTARG problem on Dec 25, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hyperbilirubinaemia, neurogenic bladder, pneumonia, venoocclusive liver disease, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Rosiglitazone Side Effects Report #5589700-8
ROSIGLITAZONE problem was reported by a Physician from SLOVAKIA (Slovak Republic) on Jan 10, 2008. Male patient, 62 years of age, weighting 155.4 lb, was treated with ROSIGLITAZONE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, hyperbilirubinaemia, hyperglycaemia, hypertriglyceridaemia, musculoskeletal chest pain, respiratory disorder, vomiting, . ROSIGLITAZONE dosage: unknown. During the same period patient was treated with METFORMIN, DIAPREL. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Cefuroxime Side Effects Report #5589702-1
Physician from INDIA reported CEFUROXIME problem on Jan 04, 2008. Male patient, 38 years of age, was diagnosed with prophylaxis and was treated with CEFUROXIME. After drug was administered, patient experienced the following problems/side effects: haemolysis, hyperbilirubinaemia, . CEFUROXIME dosage: 750MG THREE TIMES PER DAY. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Epivir Side Effects Report #5600102-8
EPIVIR problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, child 10 years of age, was diagnosed with hiv infection and was treated with EPIVIR. After drug was administered, patient experienced the following problems/side effects: headache, hyperbilirubinaemia, jaundice, ocular icterus, . EPIVIR dosage: unknown. During the same period patient was treated with ATAZANAVIR SULPHATE, ZERIT, BACTRIM, ZITHROMAX, RITALIN, ZYPREXA, AZMACORT, ALBUTEROL. Patient recovered.
HYPERBILIRUBINAEMIA : Augmentin Side Effects Report #5537419-1
Consumer or non-health professional from SPAIN reported AUGMENTIN problem on Dec 03, 2007. Male patient, 78 years of age, was diagnosed with pneumonia and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: hepatitis, hyperbilirubinaemia, . AUGMENTIN dosage: unknown. During the same period patient was treated with CIDINE, PENTOXIFYLLINE, KALPRESS, INSULIN, METFORMIN, PANTOPRAZOL. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Tazocel Side Effects Report #5545412-8
TAZOCEL problem was reported by a Physician from SPAIN on Dec 05, 2007. Female patient, 30 years of age, was diagnosed with liver abscess, fascioliasis and was treated with TAZOCEL. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage, hyperbilirubinaemia, . TAZOCEL dosage: unknown. During the same period patient was treated with PARACETAMOL, ESKAZOLE. Patient recovered.
HYPERBILIRUBINAEMIA : Augmentin Side Effects Report #5547258-3
Consumer or non-health professional from SPAIN reported AUGMENTIN problem on Dec 03, 2007. Male patient, 78 years of age, was diagnosed with pneumonia and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: hepatitis, hyperbilirubinaemia, . AUGMENTIN dosage: unknown. During the same period patient was treated with CIDINE, PENTOXIFYLLINE, KALPRESS, INSULIN, METFORMIN, PANTOPRAZOL. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Epzicom Side Effects Report #5557590-5
EPZICOM problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 07, 2007. Female patient was diagnosed with hiv infection and was treated with EPZICOM. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyperbilirubinaemia, hypersensitivity, hypotension, pyrexia, . EPZICOM dosage: unknown. During the same period patient was treated with REYATAZ, SAQUINAVIR. Patient recovered.
HYPERBILIRUBINAEMIA : Warfarin Side Effects Report #5568220-0
Health Professional from TURKEY reported WARFARIN problem on Dec 17, 2007. Male patient, 53 years of age, was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, hyperbilirubinaemia, hypotension, international normalised ratio increased, leukocytoclastic vasculitis, pulmonary oedema, skin necrosis, transaminases increased, . WARFARIN dosage: unknown. During the same period patient was treated with ENOXAPARIN. Patient was hospitalized. Patient died.
HYPERBILIRUBINAEMIA : Warfarin Side Effects Report #5575899-6
WARFARIN problem was reported by a Consumer or non-health professional from TURKEY on Dec 18, 2007. Male patient, 53 years of age, was diagnosed with rheumatic heart disease and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, hyperbilirubinaemia, international normalised ratio increased, leukocytoclastic vasculitis, pulmonary oedema, skin necrosis, transaminases increased, . WARFARIN dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Mylotarg Side Effects Report #5505514-9
Physician from JAPAN reported MYLOTARG problem on Oct 25, 2007. Female patient, weighting 116.8 lb, was diagnosed with acute myeloid leukaemia, neutropenia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, hyperbilirubinaemia, neurogenic bladder, pneumonia, . MYLOTARG dosage: unknown. During the same period patient was treated with PREDONINE, VANCOMYCIN, MEROPENEM, AMBISOME. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Primaxin Side Effects Report #5515264-0
PRIMAXIN problem was reported by a Pharmacist from MALAYSIA on Nov 07, 2007. Male patient, 52 years of age, weighting 176.4 lb, was diagnosed with nosocomial infection, pneumonitis and was treated with PRIMAXIN. After drug was administered, patient experienced the following problems/side effects: anaemia, hyperbilirubinaemia, multi-organ failure, . PRIMAXIN dosage: unknown. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient died.
HYPERBILIRUBINAEMIA : Primaxin Side Effects Report #5518811-8
Pharmacist from MALAYSIA reported PRIMAXIN problem on Nov 07, 2007. Male patient, 52 years of age, weighting 176.4 lb, was diagnosed with nosocomial infection, pneumonitis and was treated with PRIMAXIN. After drug was administered, patient experienced the following problems/side effects: anaemia, hyperbilirubinaemia, multi-organ failure, . PRIMAXIN dosage: unknown. During the same period patient was treated with ACYCLOVIR. Patient was hospitalized. Patient died on 11/06/2007.
HYPERBILIRUBINAEMIA : Bactrim Side Effects Report #5523025-1
BACTRIM problem was reported by a Pharmacist from UNITED STATES on Nov 16, 2007. Male patient was treated with BACTRIM. After drug was administered, patient experienced the following problems/side effects: hepatitis acute, hyperbilirubinaemia, liver injury, rash, transaminases increased, . BACTRIM dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Busulfan Side Effects Report #5523798-8
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Nov 05, 2007. Male patient, 21 years of age, was diagnosed with stem cell transplant, hyperbilirubinaemia and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hyperbilirubinaemia, staphylococcal sepsis, streptococcal sepsis, . BUSULFAN dosage: 33.2 ML; QD; IV. During the same period patient was treated with MICAFUNGIN, CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, CYCLOSPORINE. Patient recovered.
HYPERBILIRUBINAEMIA : Zoloft Side Effects Report #5529678-6
ZOLOFT problem was reported by a Health Professional from SWEDEN on Nov 21, 2007. Female patient was diagnosed with depression and was treated with ZOLOFT. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, hyperbilirubinaemia, transaminases increased, . ZOLOFT dosage: unknown. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Rituximab Side Effects Report #5478655-2
Physician from UNITED KINGDOM reported RITUXIMAB problem on Sept 26, 2007. Female patient, 68 years of age, weighting 172.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: hiatus hernia, hyperbilirubinaemia, hypokalaemia, pericardial effusion, . RITUXIMAB dosage: 375 MG/M2, UNK. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Sutent Side Effects Report #5487504-8
SUTENT problem was reported by a Physician from CHILE on Oct 04, 2007. Male patient was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: genital herpes, hyperbilirubinaemia, . SUTENT dosage: unknown. Patient recovered.
HYPERBILIRUBINAEMIA : Triflucan Side Effects Report #5487536-X
Health Professional from FRANCE reported TRIFLUCAN problem on Oct 04, 2007. Male patient was treated with TRIFLUCAN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hyperbilirubinaemia, jaundice, . TRIFLUCAN dosage: unknown. During the same period patient was treated with TAXOTERE, CISPLATIN, ALFUZOSIN HYDROCHLORIDE, OGAST, COLCHIMAX, ALLOPURINOL. Patient was hospitalized. Patient recovered.
HYPERBILIRUBINAEMIA : Vfend Side Effects Report #5499797-1
VFEND problem was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2007. Male patient, weighting 115.7 lb, was diagnosed with pneumonia bacterial, cardiac failure congestive and was treated with VFEND. After drug was administered, patient experienced the following problems/side effects: hyperbilirubinaemia, renal failure acute, respiratory failure, . VFEND dosage: unknown. During the same period patient was treated with BIAPENEM, ORGARAN, MINOCYCLINE, BENAMBAX, TARGOCID, GAMIMUNE N. Patient died on 08/08/2006.
HYPERBILIRUBINAEMIA : Aldurazyme Side Effects Report #5500295-7
Physician from UNITED STATES reported ALDURAZYME problem on Oct 11, 2007. Female patient, child 1 years of age, weighting 53.35 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: blood stem cell transplant failure, hyperbilirubinaemia, mucosal inflammation, staphylococcal bacteraemia, . ALDURAZYME dosage: 0.58 MG/KG QWK IV. During the same period patient was treated with CYCLOSPORINE, MYCOPHENOLATE MOFETIL, NORVASC, AVITAN, BACTRIM, NEUPOGEN, DIGOXIN, FLUCONAZOLE. Patient recovered.